X 23 (Alfuzosin Hydrochloride Extended Release 10 mg)
Pill with imprint X 23 is White, Round and has been identified as Alfuzosin Hydrochloride Extended Release 10 mg. It is supplied by Aurobindo Pharma Limited.
Alfuzosin is used in the treatment of benign prostatic hyperplasia and belongs to the drug class antiadrenergic agents, peripherally acting. There is no proven risk in humans during pregnancy. Alfuzosin 10 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for X 23
Alfuzosin Hydrochloride Extended Release
- Imprint:
- X 23
- Strength:
- 10 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Antiadrenergic agents, peripherally acting
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Aurobindo Pharma Limited
- National Drug Code (NDC):
- 65862-0249
More about alfuzosin
- Alfuzosin Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 52 Reviews
- Drug class: antiadrenergic agents, peripherally acting
Consumer resources
Other brands: Uroxatral
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
